Results 171 to 180 of about 74,767 (306)

The application of large language models in bariatric surgery: A scoping review. [PDF]

PLoS One
Guo N, Li X, Li X, Kang C, Gong X, Ji X, Zheng J.   +6 more
europepmc   +1 more source

Bariatric surgery or medicine for type 2 diabetes?\ud

, 2012
Diet and medical treatment are the standard treatment for type 2 diabetes. In obese subjects with type 2 diabetes, bariatric surgery is effective in resolving diabetes.
Chan, Vincent, Doggrell, Sheila Anne
core  

Effects of Incretin‐Based Therapies, Diet and Exercise Interventions, and Bariatric Surgery on Fat‐Free Mass in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Maintaining fat‐free mass (FFM) during weight loss is important to maintain a healthy body composition. This review examined changes in FFM during weight loss induced by diet and exercise interventions, incretin‐based therapies, and bariatric surgery, and assessed whether the relative loss of FFM differs by weight‐loss modality ...
Laura Busk‐Cirera, Ida Ørum Carlsen, Lærke Bruun Madsen, Rasmus Michael Sandsdal, Emma Jensen, Simon Birk Kjær Jensen, Signe Sørensen Torekov   +6 more
wiley   +1 more source

Mechanisms of weight recurrence after bariatric surgery. [PDF]

Nutr Metab (Lond)
Yadav RK, Zhang Y, Lv Y, Liu S, Yang J, Wang Y, Gang X.   +6 more
europepmc   +1 more source

Cost‐Effectiveness of Pharmacologic Therapies for Metabolic Dysfunction–Associated Steatohepatitis With Significant Fibrosis in the United States

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The approval of new pharmacotherapies for metabolic dysfunction‐associated steatohepatitis (MASH) presents a critical need for value assessment. We evaluated the cost‐effectiveness of resmetirom, semaglutide and tirzepatide for U.S. adults with MASH and F2–F3 fibrosis.
Ali A. Abdeen, Turgay Ayer, Aanan Biswas, Chase J. Wehrle, Sobia N. Laique, Ali Aminian   +5 more
wiley   +1 more source

Bariatric surgery and prostate cancer screening: insights into preventive men's health. [PDF]

Ann Med Surg (Lond)
Mugisha AI.
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction‐Associated Steatotic Liver Disease

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier, Ramon A. Hofmann, Michael Roden, Wolfgang Rathmann, Oliver Kuss   +4 more
wiley   +1 more source

From obesity to foot drop: A rare but reversible complication of bariatric surgery. [PDF]

Turk J Phys Med Rehabil
Ferahman D, Özkaya ES, Yalçın Ü.
europepmc   +1 more source

Association of front-of-package warning label perceptions with Mediterranean diet adherence after bariatric surgery: FOP perceptions and MedDiet adherence post-bariatric surgery. [PDF]

Obes Pillars
Milián SML, Ruiz LPP, Morales-García WC, Calizaya-Milla YE.   +3 more
europepmc   +1 more source

Effects of bariatric surgery on urinary incontinence

, 2017
Nurullah Bulbuller,1 Mani Habibi,1,2 Mustafa Yuksel,3 Onur Ozener,1 Mehmet Tahir Oruc,1 Osman Zekai Oner,1 Mehmet Altug Kazak1 1General Surgery Department, Antalya Training and Research Hospital, Antalya, 2General Surgery Department, Esenler Maternity ...
Yuksel M, Habibi M, Oruc MT, Bulbuller N, Oner OZ, Ozener O, Kazak MA   +6 more
core